학술논문

Pharmacogenetic meta-analysis of baseline risk factors, pharmacodynamic, efficacy and tolerability endpoints from two large global cardiovascular outcomes trials for darapladib
Document Type
Article
Source
In: PLoS ONE. (PLoS ONE, July 2017, 12(7))
Subject
Language
English
ISSN
19326203